For BMS, Launching New Products Is The Start Of The Battle

Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve access to lifesaving therapies. Payers and politicians must be persuaded to loosen their purse strings – and open their minds.    

BMS (Bristol) building
• Source: Shutterstock

Monica Shaw joined Bristol Myers Squibb Company as head of major markets in September. Based in Zurich, she is senior vice president and head of European markets, overseeing 22 countries – the company’s largest territories outside the US. But the industry is in a tricky place, contending with political pressure to cut drug prices and reduce spending more generally.

“It’s clear, particularly post-COVID, that a lot of payers have gone into cost containment mode. I think, for the first...

More from C-Suite Speaks

More from Leadership